- Home
- EBMT vs GNLX Comparison
EBMT vs GNLX Comparison
Compare EBMT & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- GNLX
- Stock Information
- Founded
- EBMT 1922
- GNLX 2001
- Country
- EBMT United States
- GNLX United States
- Employees
- EBMT N/A
- GNLX N/A
- Industry
- EBMT Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- GNLX Health Care
- Exchange
- EBMT Nasdaq
- GNLX Nasdaq
- Market Cap
- EBMT 127.9M
- GNLX 110.9M
- IPO Year
- EBMT N/A
- GNLX 2023
- Fundamental
- Price
- EBMT $17.62
- GNLX $2.98
- Analyst Decision
- EBMT
- GNLX Strong Buy
- Analyst Count
- EBMT 0
- GNLX 4
- Target Price
- EBMT N/A
- GNLX $17.75
- AVG Volume (30 Days)
- EBMT 95.7K
- GNLX 142.9K
- Earning Date
- EBMT 07-22-2025
- GNLX 08-13-2025
- Dividend Yield
- EBMT 3.29%
- GNLX N/A
- EPS Growth
- EBMT 26.99
- GNLX N/A
- EPS
- EBMT 1.41
- GNLX N/A
- Revenue
- EBMT $82,271,000.00
- GNLX N/A
- Revenue This Year
- EBMT N/A
- GNLX N/A
- Revenue Next Year
- EBMT $4.97
- GNLX N/A
- P/E Ratio
- EBMT $12.30
- GNLX N/A
- Revenue Growth
- EBMT 0.06
- GNLX N/A
- 52 Week Low
- EBMT $12.61
- GNLX $1.60
- 52 Week High
- EBMT $18.49
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- EBMT 67.50
- GNLX 56.10
- Support Level
- EBMT $16.36
- GNLX $2.75
- Resistance Level
- EBMT $16.86
- GNLX $3.17
- Average True Range (ATR)
- EBMT 0.51
- GNLX 0.23
- MACD
- EBMT 0.22
- GNLX -0.00
- Stochastic Oscillator
- EBMT 100.00
- GNLX 56.94
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.